News Releases

Mapi Research Trust and Mapi Language Services present scientific research works at the Annual Meeting of the American Society of Clinical PsychoPharmacology

LYON, France, May 18, 2017 /PRNewswire/ -- Mapi Research Trust, the leading curator and license distributor of Clinical Outcome Assessments (COAs) and Mapi Language Services, the most trusted provider of linguistic validation of COAs, will present a panel session and two posters at the Annual Meeting of the American Society of Clinical PsychoPharmacology (ASCP, formerly ECDEU and NCDEU) held in Miami (FL) from May 29th to June 2nd:

  • Validly and Reliably Measuring Functional Performance in Dementia Patients Across Countries and Languages in Clinical Trials, a project developed with Dr Isabelle Gelinas and inVentiv Health:

Panel session on Friday, June 2, 2017 from 8:30 AM to 10:00 AM

  • Challenges in the Translation of the Neuropsychiatric Inventory (NPI) into 74 Languages, a project developed in collaboration with Dr Jeffrey Cummings:

Poster presentation on Wednesday, May 31, 2017 from 11:15 AM1:00 PM, poster #34

  • Translation of the Zarit Burden Interview 22 Items (ZBI-22) into 95 Languages: Challenges and Importance of the Conceptual Definition of the Original Version, a project developed in collaboration with Dr Steven Zarit:

Poster presentation on Thursday, June 01, 2017 from 12:30 PM2:00 PM, poster #26

Mapi Trust collaborates with top Clinical Outcomes researchers to improve patients' Quality of Life and developing Real World Evidence in establishing value of novel treatments. Mapi and the Mapi Research Trust are the global experts in applying Clinical Outcome Assessments in Clinical Research, Real-World Evidence Generation, Evidence Synthesis,  Value communications and evaluating Patient Outcomes in Clinical care environments.

Mapi Research Trust, as the largest single COA licensing provider and the most trusted name in distribution of COA instruments exclusively representing over 300 questionnaires, and Mapi Language Services will take this opportunity to share their experience in psychiatric disorders through the availability of renown specific rating scales and their translations distributed by Mapi Research Trust on behalf of their developers and copyright holders in this domain e.g. the Disability Assessment for Dementia (DAD), the Hamilton Depression and Anxiety scales, the Hospital Anxiety and Depression Scale (HADS), the Neuropsychiatric Inventory (NPI), the Mini-International Neuropsychiatric Interview (M.I.N.I. 6.0), and many others.

To learn more about Mapi or should you be interested in meeting at the ASCP conference in Miami from May 29th to June 2nd, please contact Caroline Anfray, Director Author Collaboration Unit at Mapi Research Trust: canfray@mapigroup.com or Christelle Giroudet, Key Account Director at Mapi Language Services: cgiroudet@mapigroup.com.

About Mapi Language Services:

Mapi Language Services is the worldwide leader in medical translation and Linguistic Validation of COAs for nearly 3 decades. Mapi has first-hand knowledge of local languages and cultures, regulations, and healthcare practices. We work in close collaboration with developers, assure conceptual equivalence and international harmonization of all language versions. Mapi Language Services' experience represents more than 40,000 translated versions of 2,500 Questionnaires in 170 languages. Visit http://www.mapigroup.com for more information.

About Mapi Research Trust:
Mapi Research Trust is a Non-Profit arm of Mapi Group and works in collaboration with Academic Researchers, Life-Science Companies and Regulatory bodies. It is the largest curator of Clinical Outcomes Assessments (COA) and their translations, the largest single COA licensing provider and the most trusted name in distribution of COA instruments exclusively representing over 300 questionnaires.  Visit http://mapi-trust.org/ for more information.

Press contact: Media@mapigroup.com

Mapi Research Trust

 

Mapi Group

 

SOURCE Mapi Research Trust